CLINICAL_TRIALS
ClinicalTrials.gov record with results posted
A Phase Ib/II Study of Talazoparib and Axitinib in Metastatic Renal Cell Carcinoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04337970
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-10-07T00:04:19.147383+00:00
- Published At
- 2026-10-06T00:00:00+00:00
- Record Updated At
- 2026-10-06
- Results Posted At
- 2026-10-06
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Kidney Cancer", "Renal Cell Carcinoma", "Unresectable Renal Cell Carcinoma", "Metastatic Renal Cell Carcinoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-10-06"- protocolSection.identificationModule.nctId
"NCT04337970"- protocolSection.identificationModule.officialTitle
"A Phase Ib/II Study of Talazoparib and Axitinib in Metastatic Renal Cell Carcinoma"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-10-06"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.